1. The eye inflammation was treated with urea, a pharmaceutical compound composed of 1-phenyl-n '- (2,5-dioxin-zolpidan-1-il) derivatives, which is the throat drug of thyroid 2 receptor. (the application is divided into 201502485).

• 收藏
• 分享

专利权人:

INC.;ALLERGAN

发明人:

VISWANATH VEENA,BEARD RICHARD L.,DONELLO JOHN E.

申请号：

CL2017002526

公开号：

CL2017002526A1

申请日:

2017.10.06

申请国别(地区):

CL

年份:

2018

代理人:

摘要：

The use of a pharmaceutical compound for the treatment of ocular inflammation is described, including a compound derived from 1-phenyl-n '- (2,5-dioxin-zolpidan-1-il) urea, a promoter of the thyroid 2 receptor.SE DESCRIBE EL USO DE UNA COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE UN COMPUESTO DERIVADO DE 1-FENIL-N’-(2,5-DIOXOIMIDAZOLIDIN-1-IL)UREA, AGONISTA DEL RECEPTOR DE PÉPTIDO FORMILO 2, PARA TRATAR ENFERMEDADES INFLAMATORIAS OCULARES.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/